D
emand for primary total hip arthroplasty and demand for total knee arthroplasty in the United States are anticipated to grow by 174% and 673%, respectively, over the next twenty years 1 . Satisfaction rates are good to excellent in most patients [2] [3] [4] . Modern techniques and perioperative care have reduced systemic and local complications [5] [6] [7] . Nevertheless, the risks of major adverse outcomes (2.2% to 7.4%) [8] [9] [10] and death (0.1% to 0.8%) 5, [7] [8] [9] [11] [12] [13] [14] [15] [16] [17] [18] [19] remain real. Careful preoperative clearance and targeted therapeutic interventions are necessary to minimize complications.
Studies have demonstrated total joint arthroplasty to be a highly cost-effective procedure. Nevertheless, many payers, especially the U.S. Centers for Medicare & Medicaid Services (CMS), have targeted total joint arthroplasty for cost control 20 . Adoption of a pay-for-performance program by CMS 21 has created a zero-sum game to reward overachievers and penalize underachievers.
The current literature lacks a detailed, comprehensive approach for risk-stratifying total joint arthroplasty patients and a systematic method for preoperatively allaying these risks. Popular tools such as the American Society of Anesthesiologists (ASA) classification system may be effective in predicting the overall outcome of surgery, but they cannot predict specific complications 22 and they do not facilitate further preparatory action [23] [24] [25] . Although medical evaluation should be performed in collaboration with the internist, evidence-based guidelines provide standardization and comprehensiveness. Conditions necessitating postponement or cancellation of total joint arthroplasty are present in approximately 4% of patients 26 .
Cardiovascular Conditions
C omplications related to the cardiovascular system represent 42% to 75% of major systemic adverse events and deaths following total joint arthroplasty 7, 13, 27, 28 , and cardiovascular comorbidities are a significant risk factor for these events 14, 29 . Intramedullary instrumentation and cementation cause marrow embolization and result in cardiac stress 30 . The in-hospital prevalence of myocardial infarction is 1.8%, occurring at a mean of three days postoperatively 31 . The American College of Cardiology and the American Heart Association published guidelines for perioperative cardiovascular evaluation 32 , which are summarized in Tables I through IV. Elective surgery is not recommended within four to six weeks after implantation of a bare-metal coronary stent, twelve months after implantation of a drug-eluting stent, or four weeks after balloon angioplasty 32 . Dual antiplatelet therapy is prescribed to minimize the risk of thrombosis before endothelialization of the stent occurs 33 , and premature drug cessation is an important predictor of death and major ischemic events 34 . Substitution of heparin may not prevent complications, and thrombosis is associated with a 45% mortality rate 33 . A cardiologist should provide explicit instructions regarding pharmaceutical prophylaxis.
Ideally, elective total joint arthroplasty should be deferred for at least twelve months after stent implantation or balloon angioplasty, and aspirin should be continued throughout the perioperative period for the arthroplasty. Clopidogrel for patients with cardiac stents appears to be safe during the perioperative period, incurring only a small increased risk of bleeding and hematoma formation 35 . Implantable cardioverter-defibrillators or pacemakers should be tested within three to six months preoperatively 32 . Atrial fibrillation increases the risk of stroke by twentyfold and should be adequately controlled prior to surgery 36 . Hypertension is the foremost cause of cardiovascular disease 37 , affecting 25% of patients. Only 72% of individuals with hypertension are aware of their condition, and less than one-third are adequately treated 38 . Stage-2 hypertension (<180/110 mm Hg) is not an independent risk factor for perioperative complications, and such hypertension alone does not warrant delay of surgery 32, 39 . Antihypertensive medications should be continued perioperatively, and physicians should be vigilant for blood pressure lability and hypotensive episodes.
Although orthopaedists rarely auscultate the heart, murmurs should not be ignored. Patent foramen ovale is present in 25% of patients 40 . This is normally a benign lesion 41 , but it is described as a risk factor for cryptogenic stroke [42] [43] [44] [45] . Perioperative stroke occurs in 0.2% of total joint arthroplasty patients, and the majority of such strokes are caused by ischemia [46] [47] [48] . Percutaneous closure of a patent foramen ovale is a relatively benign procedure 42 , but it is uncertain whether it would be beneficial in high-risk patients 41 .
Rheumatoid Conditions
A pproximately 2.6% to 7% of osteoarthritic patients have psoriasis, and 7% to 42% of patients with psoriasis have arthritis 49 . Psoriatic lesions are marked by silver, scaly, round plaques, have higher bacterial counts than adjacent normal skin 50 , and are exacerbated by stress. Infection rates after total joint arthroplasty range from 2% to 17% in patients with both arthritis and psoriasis [51] [52] [53] . Skin lesions have a predilection for extensor surfaces and intertriginous folds, and it is reasonable to delay surgery and to clear the plaques if the skin near the surgical site is compromised. According to the National Psoriasis Foundation, data on the effect of psoriasis on the risk of infection are limited and conflicting 54 . Patients with rheumatoid arthritis have similar mortality risks to controls, and no consensus exists regarding whether rheumatoid arthritis is associated with an elevated risk of periprosthetic joint infection [55] [56] [57] [58] [59] [60] [61] . Well-timed arthroplasty and improved pharmacotherapy have improved survival 62 . Diseasemodifying antirheumatic drugs, anti-inflammatory drugs, and biologic agents can compromise immunity and wound-healing. Any patient with active cardiac conditions (see Table II ) should undergo specialist evaluation and treatment before consideration of total joint arthroplasty.
It is reasonable to require electrocardiogram evaluation in all patients >50 years old and within 30 days of elective total joint arthroplasty surgery. In patients with important abnormalities such as left bundle branch block and left ventricular hypertrophy with a ''strain pattern,'' stress cardiac imaging should be strongly considered.
Functional capacity should be assessed with use of a metabolic equivalent (MET) scale. Patients with adequate functional capacity to perform activities involving >4 METs (see Table III ) without experiencing symptoms can typically be cleared for surgery from a cardiovascular standpoint.
Unless contraindicated, beta-blockers are indicated for patients with at least one of the clinical risk factors in Table IV or poor cardiovascular functional capacity.
If poor functional capacity is present, patients with at least one of the clinical risk factors should be evaluated by a specialist for clearance or potential additional noninvasive testing. Patients with no risk factors are likely to receive cardiovascular clearance.
Coronary revascularization prior to noncardiac surgery has limited value and is not recommended for patients with stable coronary artery disease. It is likely beneficial only in those patients in whom it would be indicated independent of the planned surgery for reasons such as ST segment-elevation myocardial infarction, high-risk unstable angina, angina with substantial left main coronary artery stenosis, or three-vessel disease 6 . 20, 2013 Their use in the perioperative period should be weighed against the risk of a rheumatoid arthritis flare-up 63 . A short corticosteroid tapering-off period is often necessary preoperatively to counteract the stress of surgery 63 . A rheumatologist should be consulted regarding the optimal pharmaceutical regimen ( Table  V) . Sixty-one percent of patients with rheumatoid arthritis who are undergoing elective total joint arthroplasty have cervical spine instability, and >50% of these are symptomatic 64 . Cervical radiographs should always be made prior to arthroplasty surgery (Table VI) 65 . The odds ratio for death in patients with systemic lupus erythematosus compared with controls is >3 after total hip arthroplasty and 2.5 after total knee arthroplasty 66 . Additionally, this condition is associated with a greater risk of wound complications 67 . To our knowledge, no specific recommendations to prevent these risks are available.
Immunosuppression R ecipients of solid-organ transplants often require chronic corticosteroid treatment as prophylaxis against posttransplant rejection. This causes increased vulnerability to infection. The risk of opportunistic infection is highest within the first six months after renal transplantation, and such infections are associated with a 29% mortality rate 68 . Transplant recipients have elevated risks of periprosthetic infection (9%) 69 , hip prosthesis dislocation (0% to 16.7%), venous thromboembolism (1.8% to 9%), and death (42% at fifteen years) 70 . Nevertheless, total joint arthroplasty provides good results in recipients of most types of solid-organ transplants 70, 71 . Surgeons should have a high index of suspicion for early infection 71 .
Intravenous Drug Abuse, Alcoholism, and Human Immunodeficiency Virus (HIV) I ntravenous drug abuse is a risk factor for bacteremia 72 and periprosthetic joint infection 73 . In a small case series, 25% of total joint arthroplasty patients who were intravenous drug abusers developed a periprosthetic joint infection from hematogenous spread 74 . Patients with a history of intravenous drug abuse should be referred to a methadone clinic and be clean (as confirmed by intermittent physical examinations and drug screenings) for at least two years before total joint arthroplasty 74 . Infection with HIV is an independent risk factor for periprosthetic infection and has been associated with infection rates ranging from 13% to 25%. When HIV is combined with intravenous drug abuse, the infection rate is up to 60% 74, 75 . It is reasonable to require full antiviral therapy, stable CD4 counts of >200 cells/mL, low viral titers, and a clearance recommendation from an HIV specialist before considering total joint arthroplasty in patients with HIV 74, 75 . Alcohol abuse is associated with increased postsurgical morbidity 76, 77 and delirium 78 . There is a 25% risk of dislocation after total hip arthroplasty in patients who drink >72 oz (2.1 L) per day of beer or >6 oz (177 mL) per day of other alcoholic beverages [79] [80] [81] . The CAGE questionnaire 82 is the best known alcohol use questionnaire. However, a simple validated screening instrument, the AUDIT-C questionnaire (Table VII) , is highly predictive; for every 1-point increase above 1 point, complications increase by 29% 83 . Abstinence for at least one month preoperatively significantly decreases postoperative morbidity 84 , but shorter periods do not make a difference 85 . Patients who abuse alcohol should be evaluated for liver disease and malnutrition. 
Dental Pathology
A pproximately 2% of total joint arthroplasty infections involve organisms found in the oropharynx, and most affected patients have preexisting cavities or oral abscesses 86 . Dental caries or infected gums requiring treatment are present in 15% to 23% of patients undergoing total joint arthroplasty 87, 88 . Antibiotic prophylaxis before substantial dental procedures in patients who have undergone total joint arthroplasty is controversial; authors of 74% of the prior literature on the topic take no clear position 89 . The American Academy of Orthopaedic Surgeons (AAOS) suggests prophylaxis in patients at high risk of hematogenous or prosthetic infection 90 , and the American Academy of Oral Medicine (AAOM) expresses concern that those recommendations have been extended to include all patients with a total joint arthroplasty, regardless of the underlying risk 91 . Bacteremia from dental procedures can cause seeding and sepsis of the prosthetic joint [92] [93] [94] [95] . Treatable dental issues should be screened for and treated before total joint arthroplasty 86, 87, 89 .
Obesity
O besity increases the risk of complications in total joint arthroplasty patients [96] [97] [98] . One-half of total knee arthroplasty patients and one-third of total hip arthroplasty patients are obese (body mass index [BMI] > 30 kg/m 2 ) 99, 100 . The authors of nearly all studies report an increase, ranging from fourfold to nearly tenfold, in the prevalence of infection in obese and morbidly obese patients (BMI > 40 kg/m 2 ) 96, 99, [101] [102] [103] [104] . Diabetes compounds the risk associated with obesity 105 . Excess fat necessitates longer incisions and lengthier tourniquet times, resulting in more fat necrosis and greater wound complications 96, 106, 107 . Each day of prolonged drainage increases the risk of infection by 29% to 42% 108 . Obesity is associated with acetabular malpositioning 109 and dislocation in total hip arthroplasty 101, 110 and with technical errors 111 and medial collateral ligament avulsion in total knee arthroplasty 103, 106 . Super obesity (BMI > 50 kg/m 2 ) is associated with a twenty-onefold increase in the risk of infection 102 and a complication rate of >50% 112, 113 . However, some other studies do not support significant differences in complications in obese compared with nonobese patients 100, [114] [115] [116] [117] [118] . Total joint arthroplasty provides functional improvement and patient satisfaction in obese and even morbidly obese patients 104, 119 , but obesity remains a risk factor for inferior results when obese patients are matched with controls 120, 121 . For every 5-unit increase in BMI above 25 kg/m 2 , the overall risk of mortality in the general population increases by 30% 122 . Although dietary modification, drug therapy, behavioral changes, and exercise are effective in a highly motivated subset of individuals, these strategies are unsuccessful in most patients. Inability to exercise because of arthritis represents a logical reason for failure of weight-loss therapy, but morbidly obese patients often do not lose substantial weight even after total joint arthroplasty 96 . Preoperative weight loss should be recommended in morbidly obese patients and required in super-obese patients. 20, 2013 Bariatric surgery is more effective than nonoperative therapy in patients with a BMI of >40 kg/m 2 and typically results in a weight loss of 20 to 30 kg 123, 124 . The overall mortality rate and adverse event rate associated with current bariatric procedures are <1% and approximately 20%, respectively 123 . However, there is conflicting evidence regarding whether bariatric surgery performed before or after total joint arthroplasty affects complication rates 110, 125 . Obstructive sleep apnea is present in 5% to 11% of total joint arthroplasty patients [126] [127] [128] . This condition is associated with an increased prevalence of perioperative complications 129 and a longer length of stay, but these can be reduced with adequate screening and management strategies 126 . The current gold standard for diagnosing obstructive sleep apnea is an overnight sleep study involving polysomnography 130 , but the STOP-BANG questionnaire (Table VIII) can screen for highrisk patients 129 . Surgery can be delayed to definitively diagnose obstructive sleep apnea, or elective surgery can proceed with use of anesthetic and other perioperative measures to mitigate the effects of the presumptive obstructive sleep apnea 126, 129, 131 .
Hematologic Conditions
V enous thromboembolic disease is one of the greatest risks associated with total joint arthroplasty. Historically, the rate of fatal pulmonary embolism has been reported to be up to 3.4% 132 . With improved thromboprophylaxis, the rates of fatal and symptomatic nonfatal pulmonary embolism have been reported to be 0.22% 133 and 0.41%, respectively 134 . There is debate between the American College of Chest Physicians (ACCP) and the AAOS [135] [136] [137] [138] [139] [140] about the appropriate thromboprophylaxis protocol 141 . Each patient is unique (Table IX) , and the surgeon and internist should reach an agreement regarding prophylaxis. In high-risk patients who have contraindications to anticoagulation therapy 142 , failure of anticoagulation, cessation of anticoagulation therapy secondary to bleeding, or saddle emboli, inferior vena cava filters are effective in preventing pulmonary embolism (reducing the prevalence to 0% to 3.1%) [143] [144] [145] [146] . However, such filters should not be used without careful consideration because they may not affect the overall mortality rate and they are associated with an increase in the rate of primary or recurrent deep venous thrombosis [147] [148] [149] . Many such filters are removable, but actual retrieval rates are low because of thrombosis and incorporation into the vessel wall 143, 150 . Complications can occur in 11% of patients during retrieval 143, 144 . Special considerations are necessary in patients on chronic anticoagulation therapy (Table X) .
Hemoglobin levels used to define anemia range from <13 to <14.2 g/dL in men and <11.6 to <12.3 g/dL in women 151 . Anemia is not uncommon in elderly patients 152 , and it is present in 21% of patients undergoing elective orthopaedic surgery 153 . Blood transfusion after total joint arthroplasty is associated with an increased infection rate. Patients with a preoperative hemoglobin level of <13 g/dL are 4 to 5.6 times more likely to require a transfusion than patients with a level of between 13 to 15 g/dL and fifteen times more likely than patients with a level of >15 g/dL 154, 155 . Preoperative autologous donation of blood can pose administrative difficulties, and such blood has a limited shelf-life and is wasted 25% to 46% of the time [156] [157] [158] [159] . Patients without preoperative anemia did not benefit from autologous blood donation 158 , and patients who donated were less likely to receive allogeneic blood but overall they were more likely to receive a blood transfusion 156 . It is recommended that patients with a hemoglobin level of <11 g/dL undergo a work-up to identify the underlying cause of the anemia 157 . Patients with a below-normal hemoglobin level should receive multivitamins with iron supplementation to optimize their condition. Analyzed as a continuous variable rather than by category, the hemoglobin level is not a significant independent 20, 2013 risk factor for myocardial infarction or death within the first thirty days after total joint arthroplasty 160 . Hemophilia is associated with a 3% to 16% rate of infection after total joint arthroplasty [161] [162] [163] . Clotting factor infusions should be used to maintain clotting factor levels perioperatively. Although the literature regarding total joint arthroplasty in patients with hemophilic arthropathy is limited to medium-sized case series, results appear to be satisfactory, with elevated complications rates in some studies [164] [165] [166] [167] [168] [169] . Femoral head osteonecrosis affects up to 50% of patients with sickle-cell anemia 170, 171 . The rate of complications during arthroplasty is as high as 67%, with the complications including sickle-cell-related events (acute chest syndrome or vaso-occlusive crisis, in 19%), transfusion issues (12%), and surgical complications (15%) 171, 172 . Close monitoring of oxygenation, body temperature, fluid resuscitation, and acid-base balance is necessary to prevent sickle-cell-related events. Cardiomegaly and underlying congestive heart failure may accompany chronic anemia. A pain management specialist should help to manage patients with prior narcotic use. A hematologist should advise whether preoperative transfusion or plasmapheresis is indicated 173 . Patients with sicklecell anemia are often functionally asplenic and should be evaluated for latent niduses for infection 170 .
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ncreased age is associated with higher rates of medical complications and death after total joint arthroplasty 8, 13, 14, 28, [174] [175] [176] . Patients older than eighty-five years of age have a risk of in-hospital mortality that is more than ninefold greater than that of patients forty-five to sixty-four years of age 7 . The thirty-day mortality rate after total hip arthroplasty increases from 0.03% at <65 years of age to 0.07% at sixty-five to seventy-five years, 1.41% at seventy-five to eighty-five years, and 4.91% at more than eighty-five years 13 . Age alone, however, should not be a contraindication to surgery 177 . Forty percent of centenarians are functionally independent 178 . Although the overall mortality risk after total joint arthroplasty was 12% for patients who were more than 100 years old, the risk was similar to that of patients between ninety and 100 years old when adjusted for the overall mortality differences between the two groups 11 . Surgeons should carefully screen elderly patients and be prepared for higher rates of death and complications and a longer hospital stay.
Renal Conditions
U nlike coronary, cerebral, or peripheral vascular disease, renal ischemia is insidious in nature. Renal impairment is associated with a longer hospital stay, cardiac complications, early and late infections, and greater in-hospital and one-year mortality 7, 69, 179, 180 . Postoperative acute renal failure, defined as a rise in serum creatinine to more than twice the baseline value or a urine output of <0.5 mL/kg-hr for twelve hours, occurs in 0.5% of total joint arthroplasty patients 179 compared with 5% of the general hospitalized population 181 . Patients with renal insufficiency (serum creatinine > 1.5 mg/dL 182 or creatinine clearance < 100 mL/min 181 ) should be evaluated for potential treatment and preventative preoperative measures.
Total joint arthroplasty in patients on dialysis has been examined in several case series. The mean duration of dialysis before surgery was six to twelve years. Function, reduction in pain, and the implant survival rate were satisfactory 69, [183] [184] [185] . However, the rate of complications was high; a 66% rate of medical complications, a 21% rate of orthopaedic complications, and a 40% mortality at three years were reported in one study 183 . Another study demonstrated a 58% rate of early complications and mortality 186 . The reported overall prevalence of periprosthetic infection ranges from 0% to 19% 69, 184, 185, [187] [188] [189] [190] [191] . Although dialysis is not an absolute contraindication to arthroplasty, patients need an in-depth medical evaluation and extensive risk counseling.
Peripheral Vascular Conditions
V ascular complications following total joint arthroplasty are rare (0.03% to 0.5%) 192 but are usually limb-threatening or life-threatening 193 . Unpalpable peripheral pulses, intermittent claudication, pain at rest, arterial ulcers, substantial vascular calcifications, and a history of vascular insufficiency or vascular surgery should alert clinicians to at-risk patients 192, 194, 195 . If arterial insufficiency is suspected, an ankle-brachial pressure index (ABPI) should be ascertained, and referral to a vascular surgeon should be considered if the value is <0.9 196 . The timing of arterial reconstruction or bypass relative to total knee arthroplasty is controversial. Some authors recommend that vascular surgery precede total knee arthroplasty if the ABPI is <0.5 or if compromised peripheral blood supply is evident on Doppler ultrasonography 197, 198 . Total knee arthroplasty with tourniquet use (300 mm Hg) does not appear to exacerbate preexisting e19 (6) T 20, 2013 atherosclerotic disease in the presence of noncritical ischemia of the leg or to impair the arterial supply at six weeks postoperatively 199 . Patients with prior peripheral vascular bypass or angioplasty should be assessed by a vascular surgeon 192 . A tourniquet should not be used 192, 197 . Small doses of intraoperative heparin (2500 U) and a preoperative screening ultrasonogram followed by an angiogram to identify occult stenosis or occlusions may be necessary 200 . A vascular examination may be necessary immediately preoperatively to confirm vascular patency in at-risk patients 196 .
Infection P eriprosthetic infection occurs within the first two years after 0.25% of total hip arthroplasties and 2.0% of total Atrial fibrillation with history of stroke or transient ischemic attack, congestive heart failure, left ventricle dysfunction, mitral stenosis, prosthetic heart valves, thyroid disease, or age >75 yr with diabetes mellitus or hypertension 2, 11 Hypercoagulable state (Factor V Leiden, prothrombin gene mutation, antiphospholipid antibody, anticardiolipin antibody, protein-C and S deficiency, antithrombin-III deficiency) Recommendations: Stop warfarin 4 days preoperatively Therapeutic dose of LMWH or UFH preoperatively and postoperatively (discontinue 12-24 hr before surgery and resume 12-24 hr postoperatively) Resume warfarin on day of surgery Very high risk Multiple heart valves Bileaflet mitral heart valve with atrial fibrillation, congestive heart failure, or prior embolus Deep venous thrombosis <1 mo ago or 1-3 mo ago with high-risk features Recommendations: Stop warfarin 4 days preoperatively Therapeutic LMWH or UFH preoperatively and postoperatively (discontinue 12 hr before surgery and resume 12 hr postoperatively) Resume warfarin on day of surgery *LMWH = low-molecular-weight heparin, and UFH = unfractionated heparin. e19 (7) T 20, 2013 knee arthroplasties, and such infections are associated with a mortality rate of 2.7% to 18% 102, 201, 202 . Nineteen percent of all periprosthetic infections occur within the first ninety days, and 59% occur within the first two years 58 . Surgical site infections are associated with a 60% greater risk of intensive-careunit stay, a fivefold greater risk of hospital readmission, and a fivefold to elevenfold greater risk of death 203 . The prevalence of infection after total joint arthroplasty increased nearly twofold from 1990 to 2004 1 , likely because of improved medical care, wider availability of total joint arthroplasty for less healthy patients 204, 205 , and emergence of more virulent antibiotic-resistant microorganisms. Patient risk factors for infection include posttraumatic arthritis, prior surgery, chronic liver disease, corticosteroid use, alcohol or intravenous drug abuse, greater severity of comorbidities, malnutrition, anemia, obesity, and diabetes 55, 102, 202, 206 . In addition to preoperative patient optimization (e.g., glucose control and nutritional supplementation), preparations such as surgical site shaving on the day of surgery, intraoperative measures such as skin decontamination, and screening and treatment of methicillin-resistant Staphylococcus aureus (MRSA) have been shown to be effective in reducing infection 207, 208 . Twenty-three percent of patients undergoing elective orthopaedic surgery are carriers of Staphylococcus aureus, and 5% are carriers of MRSA 209 . The risk of developing a surgical site infection is sevenfold greater in carriers of MRSA compared with methicillinsensitive Staphylococcus aureus (MSSA), and most surgical site infections are attributable to community-acquired strains brought into the hospital by the patient 209 . With increasing use of vancomycin for MRSA, vancomycin-resistant enterococcal infections have been reported in arthroplasty patients 210 . The association between perioperative urinary tract infection and periprosthetic infection appears to be minimal [211] [212] [213] despite several case reports describing hematogenous seeding and delayed infection 214 . The classic urinary tract infection symptoms of dysuria and urgency and increased frequency of urination are often absent in elderly patients, and approximately 4% of total joint arthroplasty patients have asymptomatic urinary tract infections prior to surgery 212 . A rational approach to preoperative urinary tract infection based on available studies is outlined in Table XI . Short-term use of indwelling catheters is superior to intermittent straight catheterization and reduces urinary retention and bladder distention without increasing the rate of urinary tract infection 215, 216 . Urinary catheters should be removed as soon as possible 217, 218 . Patients with preoperative obstructive symptoms or bladder outflow problems should see a urologist.
Revision arthroplasty is well known to be associated with an elevated risk of infection compared with primary arthroplasty 219 . Performing a primary total joint arthroplasty for posttraumatic arthritis in a patient with a history of septic arthritis is even more hazardous. Precautionary measures include joint aspiration, analysis of the serum C-reactive protein level and erythrocyte sedimentation rate, and multiple intraoperative cultures, plus indium-labeled leukocyte scans in select cases 220 . Primary total joint arthroplasty should be delayed for at least one year after resolution of a known infection; if the levels of any of the inflammatory markers indicate ongoing infection, the arthroplasty should be further delayed until normalization of these indices. Patients with a prior fracture 221 and/or local infection should be extensively screened and counseled prior to surgery.
Corticosteroid injections are often used with local anesthetics for conservative management of osteoarthritis. Although there is no conclusive evidence, corticosteroid injections may predispose patients to septic arthritis after total joint arthroplasty 222, 223 . Most orthopaedists prefer to delay total joint arthroplasty until two to three months after corticosteroid injection.
Pulmonary Conditions and Smoking
A cute hypoxic episodes (peripheral oxygen saturation [SpO 2 ], 65% to 89%) occur in 4% of total joint arthroplasty patients during hospitalization. Although most of these episodes are due to atelectasis or unknown causes, some are secondary to important lung conditions including pneumonia, pulmonary edema, bronchospasm, and exacerbation of chronic lung disease 224 . Pulmonary complications are strongly associated with comorbidities that are clinically identifiable, and there is no consensus regarding whether preoperative testing such as spirometry or arterial blood gas analysis is routinely necessary 176, 225 . Elective total joint arthroplasty should be delayed in patients experiencing acute exacerbation of chronic obstructive pulmonary disease (COPD). The relative risk of complications for patients with COPD ranges from 2.7 to 4.7 [226] [227] [228] , and COPD should be treated aggressively with standard measures (bronchodilators, therapy, corticosteroids, and/or smoking cessation) before the arthroplasty to achieve optimum exercise capacity and maximum symptom reduction 225 . If sputum or bronchoalveolar fluid suggest infection, the surgery should be postponed and antibiotics should be administered 229 .
The prevalence of perioperative bronchospasm in patients with asthma is 1.7% 230 . To minimize complications, patients should be free of wheezing and have a peak flow that is >80% of the predicted value or the personal best value 231 . A short course of perioperative oral corticosteroids to treat asthma does not 20, 2013 increase the risk of infection or complications 232, 233 . Inhaled beta-2 adrenergic agonists and anticholinergic agents should be administered until the day of surgery in symptomatic asthmatics 234 . The effect of viral upper respiratory infection prior to surgery on pulmonary events is unknown, but it is reasonable to delay surgery in severe cases 225 . Pulmonary hypertension is rare (0.4%) after total joint arthroplasty 235, 236 . It is associated with a fourfold increase in mortality (2.4% compared with 0.6% for total hip arthroplasty and 0.9% compared with 0.2% for total knee arthroplasty). Primary pulmonary hypertension is associated with the greatest risk of mortality (5%) and warrants preoperative consultation with a pulmonologist 235, 236 . The detrimental effects of smoking on the immune system 237 and on oxygen delivery to healing tissues 238 are well known. Infection, hematoma, and wound complication rates are significantly lower in patients who cease smoking at least six to eight weeks prior to total joint arthroplasty compared with persistent smokers [239] [240] [241] . Whether those benefits are evident for patients who do not quit until one to three weeks preoperatively is controversial [240] [241] [242] [243] . Intense intervention consisting of nicotine replacement therapy and one-on-one sessions with a professional counselor is effective. However, less-involved measures such as counseling alone, pharmacotherapy alone, or a combination of pharmacotherapy with short-term counseling only two to three weeks before surgery, informal counseling sessions, or written instructions are not 240, 244 . There is no evidence that nicotine replacement therapy has an adverse effect on wound-healing 240 . Surgery is a motivational opportunity for patients to quit the highly addictive habit 245 . On average, preoperative smoking cessation is associated with a 41% relative reduction in the risk of postoperative complications, and the reduction is 19% for each week of cessation 246 .
Hepatic Conditions and Malnutrition
H epatic failure results in an impairment of neutrophil function and a reduction in the removal capacity of the reticuloendothelial system 247, 248 . Mean survival for patients who develop cirrhosis after a prior major complication such as ascites, jaundice, encephalopathy, or variceal bleeding is 1.6 years 249 . Twenty-six complications were reported after total knee arthroplasty in a study of sixty patients with Child class-A cirrhosis (bilirubin < 1.5 mg/dL, albumin > 3.5 g/dL, prothrombin time < 4 sec prolonged, no encephalopathy, no ascites 249 ) due to alcoholism or hepatitis 250 . Blood loss was elevated despite precautions, and infection occurred in 21% of the patients. Older age, a low platelet count, and hepatitis-B-related cirrhosis were independent risk factors for infection. A history of hepatic decompensation and a history of variceal bleeding were predictors of complications, and hepatoma was a predictor of mortality 250 . Another study indicated that emergency total hip arthroplasty for hip fractures in Child class-A or B patients resulted in high rates of complications and death, whereas only two major and four minor complications occurred after elective total joint arthroplasty in twenty-five patients 251 . Total joint arthroplasty is not advised for patients with cirrhosis if they have a history of hepatic decompensation or variceal bleeding, or if the cirrhosis is Child class C or possibly class B.
Malnutrition is associated with longer hospital stays 252 , infection 253 , and a fivefold to sevenfold greater risk of developing major wound complications after total joint arthroplasty 254, 255 . Occult malnutrition in healthy patients and paradoxical malnutrition in obese patients are not uncommon. Nutritional deficiency should be screened for in at-risk patients with cachexia, morbid obesity, malignancy, or a history of woundhealing issues or alcoholism 201 . Laboratory values that have been reported to be predictive of significantly increased complications vary 252, 253, 256, 257 , but diagnostic levels are described in Table XII . Malnourished patients should be referred to a nutritionist for optimization.
Diabetes
D
iabetes mellitus affects 8% to 10% of patients undergoing total joint arthroplasty 258, 259 , and 25% of diabetics are unaware that they have this condition 260 . The risks of major, minor, local, and systemic complications are all elevated postoperatively and during hospitalization 31, 102, [261] [262] [263] [264] [265] . Preadmission hyperglycemia has been shown to be an independent risk factor for inhospital symptomatic pulmonary embolism 266 . Surgery on patients with poorly controlled blood glucose levels should be delayed until hemoglobin A1C levels are satisfactory and a proper pharmacological regimen is established. The American Diabetes Association and the American Association of Clinical Endocrinologists recommend a target hemoglobin A1C level of <7.0%; for hospitalized patients who are not critically ill, they recommend a blood glucose level of <140 mg/dL before meals and a random blood glucose level of <180 mg/dL 267 . Patients with uncontrolled diabetes mellitus had higher odds of stroke, urinary tract infection, ileus, postoperative hemorrhage, wound infections, and death compared with patients with controlled diabetes 258 . Type-I and type-II diabetics have similarly elevated risks compared with nondiabetics 258, 268 . Surgery should be scheduled for early in the day, and a basal-bolus rather than a sliding-scale insulin regimen should be used 261 .
Conclusion
R isk stratification and appropriate preoperative management of comorbidities will decrease adverse events after total joint arthroplasty. Impending modifications to existing reimbursement plans in the United States include financial incentives that will pressure hospitals to adopt evidence-based algorithms and optimize patient safety. Nevertheless, although 90% of complications occur within four days of surgery, fewer than 50% of patients with life-threatening complications have identifiable predisposing factors. Orthopaedists must remain 
